The University of Chicago Header Logo

Connection

Richard A. Larson to Histocompatibility Antigens Class II

Back to Details
This is a "connection" page, showing publications Richard A. Larson has written about Histocompatibility Antigens Class II.
Richard A. Larson
Connection Strength
0.101
Histocompatibility Antigens Class II
  1. Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502. J Clin Oncol. 2013 Mar 01; 31(7):923-9.
    View in: PubMed
    Score: 0.101
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.